Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASTRO 2022 | Latest advances in tumour genetics research for prostate cancer

Omar Mian • 25 Oct 2022
ASTRO 2022
Genitourinary Cancer Prostate Cancer

Omar Mian, MD, PhD, Cleveland Clinic, Cleveland, OH, discusses latest research into tumour genetics for the development of predictive and prognostic biomarkers for prostate cancer. Dr Mian describes the various techniques that have been used to discover a range of genetic variants. This interview took place at the American Society for Radiation Oncology (ASTRO) 2022 Congress in San Antonio, Tx.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Omar Mian

2:34
Translating cancer genetics and epigenetics research into clinical practice
Omar Mian • 25 Oct 2022
3:12
Impact of HSD3B1 gene alterations on treatment response in patients with prostate cancer
Omar Mian • 25 Oct 2022
2:31
18F-clofarabine as a predictive biomarker for response to DCK-dependent chemotherapeutics
Omar Mian • 25 Oct 2022
1:14
Role of cancer epigenetics in tumour classification
Omar Mian • 25 Oct 2022

Related Videos

3:07
Serum thymidine kinase 1 as a predicative biomarker in prostate cancer
Teemu Murtola • 9 Apr 2024
2:44
The effect of hypoxia on lipid metabolism and prostate cancer tumor growth
Teemu Murtola • 9 Apr 2024
2:26
Prognostic factors of renal cell cancer in elderly patients
Teemu Murtola • 9 Apr 2024
0:57
Real-world outcomes of 177Lu-PSMA-617 in mCRPC
Hannah McManus • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals